CGM Experience, Preferences & Blood Glucose Parameters
- Sponsor
- Getz Pharma
- Study ID
- NCT07607015
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Diabete Mellitus
- Gestational Diabetes
- Pre Diabetes
- Type2diabetes
- type1diabetes
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- CGM — DEVICEComparison of 2 devices by HCP
Study Details
This is an open-label, prospective, multicenter observational study designed to evaluate the perceived benefits, device experience, preference, and glucose-related parameters associated with the Instara-1 Continuous Glucose Monitoring device. The study will include patients with diabetes and healthcare professionals. Patients will use Instara- 1 and will be followed up to assess device experience, glucose parameters, and diabetes-related quality of life. Healthcare professionals will evaluate device experience and preference, including comparison with FreeStyle Libre 2.
Key Dates
- First listed
- May 26, 2026
- Start date
- Sep 10, 2026
- Status verified
- May 2026
- Primary completion
- Aug 10, 2027
- Completion
- Aug 10, 2027
Study Design
- Enrollment
- 75 participants (estimated)
Arms
- Arm: Instara-1 CGMParticipants in this arm will use the Instara-1 Continuous Glucose Monitoring . Patients will be followed for device experience, perceived benefits, preference, glucose-related parameters, and diabetes-related quality of life. Healthcare professionals will assess device experience and preference, including comparison with FreeStyle Libre 2 where applicable.
Primary Outcome Measure
Benefit, device experience and preference of continuous glucose monitoring by patients and HCPs [ Time Frame: From enrollment to the end of treatment at 3 weeks. ]
Central Contacts
- Jahanzeb Kamal Khan, MCPS+923201212945
- Nauman Muhammad Sheikh, MBBS+923201212981
Related Studies
- Inflammation, Diabetes, Ethnicity and Obesity CohortRecruiting · University of California, San Francisco · San Francisco, California
- Genetics Of Autoimmunity In Type I DiabetesRecruiting · Medical College of Wisconsin · Milwaukee, Wisconsin
- Type 1 Diabetes Management Using a Very Low Carbohydrate Versus Standard DietRecruiting · Boston Children's Hospital · Boston, Massachusetts
- Immediate Postpartum Glucose Tolerance TestingRecruiting · MemorialCare Health System · Long Beach, California